Daré Bioscience to Present Phase 1 Sildenafil Cream Data

Daré Bioscience said its Medical Director Annie Thurman will present phase 1 adverse event and relative bioavailability data comparing topical sildenafil cream versus oral sildenafil at the SMSNA annual fall scientific meeting.